UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5497

2021

Volltextzugriff (PDF)

Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways

Journal of translational medicine, 2023-04, Vol.21 (1), p.271-271, Article 271

2023

Volltextzugriff (PDF)

Immune-Mediated Pathogenesis in Dengue Virus Infection

Viruses, 2022-11, Vol.14 (11), p.2575

2022

Volltextzugriff (PDF)

Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial

Trials, 2020-10, Vol.21 (1), p.897-5, Article 897

2020

Volltextzugriff (PDF)

Current Trends and Limitations in Dengue Antiviral Research

Tropical medicine and infectious disease, 2021-09, Vol.6 (4), p.180

2021

Volltextzugriff (PDF)

Dengue Infections in Colombia: Epidemiological Trends of a Hyperendemic Country

Tropical medicine and infectious disease, 2020-10, Vol.5 (4), p.156

2020

Volltextzugriff (PDF)

Coronavirus Disease 2019–Associated Mucormycosis: Risk Factors and Mechanisms of Disease

Clinical infectious diseases, 2022-04, Vol.74 (7), p.1279-1283

2022

Volltextzugriff (PDF)

Evolution of Nipah Virus Infection: Past, Present, and Future Considerations

Tropical medicine and infectious disease, 2021-02, Vol.6 (1), p.24

2021

Volltextzugriff (PDF)

RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects

Microorganisms (Basel), 2024-03, Vol.12 (3), p.599

2024

Volltextzugriff (PDF)

Evaluation of Four Humanized NOD-Derived Mouse Models for Dengue Virus-2 Infection

Pathogens (Basel), 2024-07, Vol.13 (8), p.639

2024

Volltextzugriff (PDF)

A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains

Microorganisms (Basel), 2023-06, Vol.11 (6), p.1548

2023

Volltextzugriff (PDF)

Humanized Mice in Dengue Research: A Comparison with Other Mouse Models

Vaccines (Basel), 2020-01, Vol.8 (1), p.39

2020

Volltextzugriff (PDF)

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection

Journal of medical virology, 2023-01, Vol.95 (1), p.e28105-n/a

2023

Volltextzugriff (PDF)

COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings

Journal of general internal medicine : JGIM, 2020-11, Vol.35 (11), p.3359-3360

2020

Volltextzugriff (PDF)

COVID-19 Vaccines-All You Want to Know

Seminars in respiratory and critical care medicine, 2023-02, Vol.44 (1), p.143-172

2023

Volltextzugriff (PDF)

Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial

The Lancet infectious diseases, 2024-08, Vol.24 (8), p.896-908

2024

Volltextzugriff (PDF)

Humanized Mice for the Study of Dengue Disease Pathogenesis: Biological Assays

Methods in molecular biology (Clifton, N.J.), 2022, Vol.2409, p.271

2022

Volltextzugriff (PDF)

Tick-borne Infections in the United States

Primary care, 2013-09, Vol.40 (3), p.619-635

2013

Volltextzugriff (PDF)

Quantification of Hepatitis B Surface Antigen: Is there a Role in HIV-Hepatitis B Virus Coinfection?

AIDS reviews, 2019, Vol.21 (4), p.175-183

2019

Volltextzugriff (PDF)

A rare case of Sphingomonas paucimobilis ventriculitis

Germs (Bucureşti), 2023-09, Vol.13 (3), p.254-258

2023

Volltextzugriff (PDF)

Increased risk of severe COVID-19 in pregnancy in a multicenter propensity score-matched study

Journal of perinatal medicine, 2023-11, Vol.51 (9), p.1171-1178

2023

Volltextzugriff (PDF)

Are we nearing the end in the fight against hepatitis C?

Expert review of gastroenterology & hepatology, 2017-06, Vol.11 (6), p.499-500

2017

Volltextzugriff (PDF)

Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study

Journal of medical virology, 2021-06, Vol.93 (6), p.3752-3760

2021

Volltextzugriff (PDF)

Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patients

Antiviral therapy, 2019, Vol.24 (1), p.11-17

2019

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression

Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways

Immune-Mediated Pathogenesis in Dengue Virus Infection

Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial

Current Trends and Limitations in Dengue Antiviral Research

Dengue Infections in Colombia: Epidemiological Trends of a Hyperendemic Country

Coronavirus Disease 2019–Associated Mucormycosis: Risk Factors and Mechanisms of Disease

Evolution of Nipah Virus Infection: Past, Present, and Future Considerations

RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects

Evaluation of Four Humanized NOD-Derived Mouse Models for Dengue Virus-2 Infection

A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains

Humanized Mice in Dengue Research: A Comparison with Other Mouse Models

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection

COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings

COVID-19 Vaccines-All You Want to Know

Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial

Humanized Mice for the Study of Dengue Disease Pathogenesis: Biological Assays

Tick-borne Infections in the United States

Quantification of Hepatitis B Surface Antigen: Is there a Role in HIV-Hepatitis B Virus Coinfection?

A rare case of Sphingomonas paucimobilis ventriculitis

Increased risk of severe COVID-19 in pregnancy in a multicenter propensity score-matched study

Are we nearing the end in the fight against hepatitis C?

Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study

Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patients

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial

Suchergebnisse filtern